Fate Therapeutics updates its Schedule 13D/A, revealing Redmile Capital Offshore II Master Fund has surpassed 5% ownership, indicating strong investor interest.
| Name | FATE THERAPEUTICS INC |
|---|---|
| CIK | 0001434316 |
| Tickers | FATE |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 651311552 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | 858.875.1803 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Fate Therapeutics updates its Schedule 13D/A, revealing Redmile Capital Offshore II Master Fund has surpassed 5% ownership, indicating strong investor interest.
Fate Therapeutics Inc. files a new S-3 registration statement, allowing for up to $300 million in securities offerings as it seeks to raise capital.
Fate Therapeutics has entered a sales agreement for a $100 million common stock offering to support its clinical trials in cellular immunotherapy.
Fate Therapeutics Inc. reports its Q3 2026 results, highlighting advancements in its product pipeline and financial position amid a competitive biotech landscape.
Fate Therapeutics, Inc. announces its financial results for Q3 2026, showcasing developments in its operations and their implications for the biological products industry.
858 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003536 | 333-299862 | 261548841 | 33 | 1708 | ||
| 2026-11-12 | 424B5 | 424B5 | 0001193125-26-458736 | 333-299862 | 261548171 | 33 | 379878 | |||
| 2026-11-09 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000905148-26-004718 | 005-87649 | 261537458 | 34 | 31965 | |||
| 2026-11-05 | S-3 | S-3 | 0001193125-26-450034 | 333-299862 | 261528117 | 33 | 649206 | 1 | 1 | |
| 2026-11-05 | 424B5 | 424B5 | 0001193125-26-450013 | 333-275402 | 261528023 | 33 | 388826 | |||
| 2026-11-05 | 8-K | 8-K | 1.01,1.02,9.01 | 0001193125-26-449840 | 001-36076 | 261527424 | 34 | 451182 | 1 | 1 |
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-448543 | 001-36076 | 261524726 | 34 | 12930970 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-448530 | 001-36076 | 261524694 | 34 | 450738 | 1 | 1 |
| 2026-11-04 | 4 | 4 | 0001193125-26-447171 | 5474 | ||||||
| 2026-11-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007696 | 001-36076 | 261516963 | 33 | 4389 | |||
| 2026-09-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-403429 | 001-36076 | 261412022 | 34 | 177935 | 1 | 1 |
| 2026-08-13 | S-8 | S-8 | 0001193125-26-349151 | 333-298302 | 261273229 | 33 | 187300 | 1 | 1 | |
| 2026-08-13 | 10-Q | 10-Q | 0001193125-26-347988 | 001-36076 | 261270211 | 34 | 11539167 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-347984 | 001-36076 | 261270205 | 34 | 435637 | 1 | 1 |
| 2026-08-05 | 4 | 4 | 0001193125-26-335019 | 5523 | ||||||
| 2026-08-05 | 4 | 4 | 0001193125-26-335007 | 5500 | ||||||
| 2026-08-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005627 | 001-36076 | 261239533 | 33 | 4999 | |||
| 2026-08-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005625 | 001-36076 | 261239421 | 33 | 5079 | |||
| 2026-07-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-001939 | 005-87649 | 261161290 | 34 | 10799 | |||
| 2026-06-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-074130 | 9334 | ||||||
| 2026-06-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-074126 | 7455 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271090 | 5771 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271088 | 5762 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271083 | 5778 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271079 | 5770 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271074 | 5767 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271072 | 5732 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271069 | 5711 | ||||||
| 2026-06-15 | 3 | 3 | 0001193125-26-271062 | 11623 | ||||||
| 2026-06-15 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-271055 | 001-36076 | 261090711 | 34 | 784647 | 1 | 1 |
| 2026-06-04 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-257558 | 001-36076 | 261065574 | 34 | 15332674 | 1 | 1 |
| 2026-05-21 | 4 | 4 | 0001193125-26-234390 | 5599 | ||||||
| 2026-05-21 | 4 | 4 | 0001193125-26-234380 | 5576 | ||||||
| 2026-05-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003833 | 001-36076 | 261003711 | 33 | 4481 | |||
| 2026-05-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003832 | 001-36076 | 261003701 | 33 | 4408 | |||
| 2026-05-13 | 10-Q | 10-Q | 0001193125-26-220696 | 001-36076 | 26971083 | 34 | 9954195 | 1 | 1 | |
| 2026-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-220691 | 001-36076 | 26971065 | 34 | 378405 | 1 | 1 |
| 2026-05-07 | 4 | 4 | 0001193125-26-211820 | 10661 | ||||||
| 2026-05-06 | 4 | 4 | 0001193125-26-208899 | 6690 | ||||||
| 2026-05-06 | 4 | 4 | 0001193125-26-208891 | 8559 | ||||||
| 2026-04-24 | ARS | ARS | 0001193125-26-177241 | 001-36076 | 26893842 | 34 | 4409006 | |||
| 2026-04-24 | DEFA14A | DEFA14A | 0001193125-26-177171 | 001-36076 | 26893724 | 34 | 135787 | |||
| 2026-04-24 | DEF 14A | DEF 14A | 0001193125-26-177094 | 001-36076 | 26893509 | 34 | 2781196 | 1 | 1 | |
| 2026-04-23 | 4/A | OWNERSHIP DOCUMENT | 0001104659-26-047974 | 15692 | ||||||
| 2026-04-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-047072 | 31191 | ||||||
| 2026-04-22 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-047066 | 005-87649 | 26885318 | 34 | 28045 | |||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001228 | 005-87649 | 26800047 | 34 | 7138 | |||
| 2026-02-26 | 10-K | 10-K | 0001193125-26-073699 | 001-36076 | 26682010 | 34 | 19766374 | 1 | 1 | |
| 2026-02-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-073689 | 001-36076 | 26681994 | 34 | 435152 | 1 | 1 |
| 2026-01-16 | 4 | 4 | 0001193125-26-015328 | 7270 | ||||||
| 2026-01-16 | 4 | 4 | 0001193125-26-015323 | 7216 | ||||||
| 2026-01-16 | 4 | 4 | 0001193125-26-015294 | 7250 | ||||||
| 2026-01-12 | 4 | 4 | 0001193125-26-010356 | 5487 | ||||||
| 2026-01-12 | 4 | 4 | 0001193125-26-010352 | 5363 | ||||||
| 2026-01-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000240 | 001-36076 | 26522765 | 33 | 4407 | |||
| 2026-01-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000239 | 001-36076 | 26522762 | 33 | 4484 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007928 | 001-36076 | 251608425 | 33 | 5329 | |||
| 2025-11-13 | 10-Q | 10-Q | 0001193125-25-279096 | 001-36076 | 251475610 | 34 | 12824064 | 1 | 1 | |
| 2025-11-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-279091 | 001-36076 | 251475605 | 34 | 473432 | 1 | 1 |
| 2025-10-27 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-250674 | 001-36076 | 251417419 | 34 | 189470 | 1 | 1 |
| 2025-10-21 | 4 | 4 | 0001193125-25-245106 | 7054 | ||||||
| 2025-10-21 | 3 | 3 | 0001193125-25-245098 | 14454 | ||||||
| 2025-10-20 | S-8 | S-8 | 0001193125-25-243708 | 333-290972 | 251404464 | 33 | 197069 | 1 | 1 | |
| 2025-10-14 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-25-238989 | 001-36076 | 251391711 | 34 | 279928 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193805-25-001193 | 005-87649 | 251219889 | 34 | 8262 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000769993-25-000505 | 005-87649 | 251215863 | 34 | 17037 | |||
| 2025-08-12 | 10-Q | 10-Q | 0000950170-25-107309 | 001-36076 | 251206752 | 34 | 12234043 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,2.05,9.01 | 0001193125-25-178947 | 001-36076 | 251206679 | 34 | 239883 | 1 | 1 |
| 2025-08-05 | 4 | 4 | 0000950170-25-102983 | 5385 | ||||||
| 2025-08-05 | 4 | 4 | 0000950170-25-102979 | 5361 | ||||||
| 2025-08-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004933 | 001-36076 | 251181215 | 33 | 4405 | |||
| 2025-08-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004926 | 001-36076 | 251180506 | 33 | 4485 | |||
| 2025-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000879 | 005-87649 | 251159910 | 34 | 6176 | |||
| 2025-07-03 | 3 | OWNERSHIP DOCUMENT | 0001104659-25-065775 | 11533 | ||||||
| 2025-07-03 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-065772 | 005-87649 | 251105496 | 34 | 22235 | |||
| 2025-06-17 | 8-K/A | 8-K/A | 5.07 | 0001193125-25-142037 | 001-36076 | 251053237 | 34 | 140475 | 1 | 1 |
| 2025-06-04 | S-8 | S-8 | 0001193125-25-134875 | 333-287765 | 251023053 | 33 | 67800 | |||
| 2025-05-30 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-055046 | 7352 | ||||||
| 2025-05-30 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-055045 | 9124 | ||||||
| 2025-05-30 | 8-K | 8-K | 5.02,5.03,5.07,7.01,9.01 | 0001193125-25-132301 | 001-36076 | 251012208 | 34 | 558834 | 1 | 1 |
| 2025-05-30 | 4 | 4 | 0000950170-25-079720 | 14947 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079719 | 14994 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079717 | 14934 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079716 | 14819 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079715 | 14951 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079712 | 14979 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079711 | 5294 | ||||||
| 2025-05-30 | 4 | 4 | 0000950170-25-079710 | 14934 | ||||||
| 2025-05-30 | 3 | 3 | 0000950170-25-079682 | 14312 | ||||||
| 2025-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193805-25-000667 | 005-87649 | 25954128 | 34 | 8155 | |||
| 2025-05-13 | 10-Q | 10-Q | 0000950170-25-070285 | 001-36076 | 25939892 | 34 | 10373058 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-070280 | 001-36076 | 25939847 | 34 | 406436 | 1 | 1 |
| 2025-05-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000769993-25-000238 | 005-87649 | 25929228 | 34 | 16374 | |||
| 2025-04-23 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-001497 | 005-87649 | 25863234 | 34 | 10815 | |||
| 2025-04-17 | ARS | ARS | 0001193125-25-084322 | 001-36076 | 25847386 | 34 | 1627106 | |||
| 2025-04-17 | DEFA14A | DEFA14A | 0001193125-25-084316 | 001-36076 | 25847338 | 34 | 137112 | |||
| 2025-04-17 | DEF 14A | DEF 14A | 0001193125-25-084310 | 001-36076 | 25847282 | 34 | 2674266 | 1 | 1 | |
| 2025-04-07 | PRE 14A | PRE 14A | 0001193125-25-074632 | 001-36076 | 25818083 | 34 | 2690430 | 1 | 1 | |
| 2025-03-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-001767 | 001-36076 | 25714600 | 33 | 5915 | |||
| 2025-03-05 | 10-K | 10-K | 0000950170-25-033510 | 001-36076 | 25710824 | 34 | 17521572 | 1 | 1 | |
| 2025-03-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-033507 | 001-36076 | 25710813 | 34 | 461798 | 1 | 1 |
| 2025-01-16 | 4 | 4 | 0000950170-25-006318 | 5377 | ||||||
| 2025-01-16 | 4 | 4 | 0000950170-25-006311 | 7174 | ||||||
| 2025-01-16 | 4 | 4 | 0000950170-25-006310 | 7194 | ||||||
| 2025-01-13 | 4 | 4 | 0000950170-25-004825 | 5514 | ||||||
| 2025-01-13 | 4 | 4 | 0000950170-25-004823 | 5495 | ||||||
| 2025-01-13 | 4 | 4 | 0000950170-25-004814 | 5455 | ||||||
| 2025-01-10 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000245 | 001-36076 | 25522574 | 33 | 4492 | |||
| 2025-01-10 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000242 | 001-36076 | 25522540 | 33 | 4438 | |||
| 2025-01-10 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000241 | 001-36076 | 25522539 | 33 | 4414 | |||
| 2025-01-06 | 8-K | 8-K | 5.02,9.01 | 0001193125-25-002153 | 001-36076 | 25510975 | 34 | 218957 | 1 | 1 |
| 2024-12-26 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-131794 | 24324 | ||||||
| 2024-12-26 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-24-131793 | 005-87649 | 241582070 | 34 | 26822 | |||
| 2024-12-20 | 144 | xsl144X01/primary_doc.xml | 0001104659-24-130954 | 001-36076 | 241569501 | 33 | 6123 | |||
| 2024-12-16 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-129070 | 12409 | ||||||
| 2024-11-29 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-268003 | 001-36076 | 241515974 | 34 | 175005 | 1 | 1 |
| 2024-11-14 | SC 13G/A | FATE THERAPEUTICS, INC. | 0000902664-24-006648 | 005-87649 | 241465301 | 34 | 74580 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-125317 | 001-36076 | 241447866 | 34 | 10659291 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-125307 | 001-36076 | 241447800 | 34 | 406940 | 1 | 1 |
| 2024-11-08 | SC 13G/A | us31189p1021_110824.txt | 0002012383-24-004004 | 005-87649 | 241442018 | 34 | 13810 | |||
| 2024-10-25 | SC 13G/A | ff4031858_13ga1-fate.htm | 0000895345-24-000479 | 005-87649 | 241398237 | 34 | 220162 | |||
| 2024-10-21 | SC 13G/A | us31189p1021_102124.txt | 0002012383-24-000958 | 005-87649 | 241383579 | 34 | 13798 | |||
| 2024-08-30 | 8-K | 8-K | 1.01,5.02,9.01 | 0001193125-24-211130 | 001-36076 | 241270391 | 34 | 250772 | 1 | 1 |
| 2024-08-21 | 3 | 3 | 0000950170-24-099503 | 19578 | ||||||
| 2024-08-13 | 10-Q | 10-Q | 0000950170-24-096187 | 001-36076 | 241201445 | 34 | 10128297 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-096177 | 001-36076 | 241201403 | 34 | 401216 | 1 | 1 |
| 2024-08-07 | 4 | 4 | 0000950170-24-092718 | 4532 | ||||||
| 2024-08-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-005350 | 001-36076 | 241177762 | 33 | 4365 | |||
| 2024-07-31 | 4 | 4 | 0000950170-24-088775 | 5386 | ||||||
| 2024-07-31 | 4 | 4 | 0000950170-24-088770 | 5203 | ||||||
| 2024-07-31 | 4 | 4 | 0000950170-24-088769 | 5421 | ||||||
| 2024-07-31 | 3 | 3 | 0000950170-24-088766 | 12975 | ||||||
| 2024-07-31 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-189911 | 001-36076 | 241161847 | 34 | 174891 | 1 | 1 |
| 2024-06-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-070507 | 7351 | ||||||
| 2024-06-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-070506 | 9120 | ||||||
| 2024-06-11 | 4 | 4 | 0000950170-24-071970 | 5604 | ||||||
| 2024-06-11 | 4 | 4 | 0000950170-24-071959 | 5639 | ||||||
| 2024-06-11 | 4 | 4 | 0000950170-24-071950 | 5695 | ||||||
| 2024-06-11 | 4 | 4 | 0000950170-24-071948 | 5615 | ||||||
| 2024-06-11 | 4 | 4 | 0000950170-24-071947 | 5643 | ||||||
| 2024-06-11 | 4 | 4 | 0000950170-24-071945 | 5498 | ||||||
| 2024-06-11 | 4 | 4 | 0000950170-24-071941 | 5491 | ||||||
| 2024-06-10 | S-8 | S-8 | 0001193125-24-158427 | 333-280097 | 241033672 | 33 | 67835 | |||
| 2024-06-10 | 8-K | 8-K | 5.03,9.01 | 0001193125-24-158374 | 001-36076 | 241033201 | 34 | 157236 | 1 | 1 |
| 2024-06-07 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-24-157554 | 001-36076 | 241030771 | 34 | 273930 | 1 | 1 |
| 2024-05-31 | 8-K | 8-K | 5.02 | 0001193125-24-151963 | 001-36076 | 241010852 | 34 | 141950 | 1 | 1 |
| 2024-05-09 | 10-Q | 10-Q | 0000950170-24-056869 | 001-36076 | 24930399 | 34 | 9039414 | 1 | 1 | |
| 2024-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-056852 | 001-36076 | 24930331 | 34 | 358692 | 1 | 1 |
| 2024-05-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-134840 | 001-36076 | 24928857 | 34 | 192706 | 1 | 1 |
| 2024-05-02 | 424B3 | 424B3 | 0001193125-24-129342 | 333-278792 | 24908010 | 33 | 289043 | |||
| 2024-04-29 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-29 16:30:00 | 9999999995-24-001190 | 333-278792 | 24893787 | 33 | 1714 | ||
| 2024-04-26 | ARS | ARS | 0001193125-24-118086 | 001-36076 | 24883996 | 34 | 11392982 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0001193125-24-118056 | 001-36076 | 24883794 | 34 | 665274 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0001193125-24-117981 | 001-36076 | 24883611 | 34 | 3237960 | 1 | 1 | |
| 2024-04-25 | CORRESP | filename1.htm | 0001193125-24-113811 | 10955 | ||||||
| 2024-04-24 | UPLOAD | filename1.pdf | 0000000000-24-004575 | 333-278792 | 40247 | |||||
| 2024-04-18 | S-3 | S-3 | 0001193125-24-100748 | 333-278792 | 24854277 | 33 | 395038 | |||
| 2024-04-16 | PRE 14A | PRE 14A | 0001193125-24-097724 | 001-36076 | 24847834 | 34 | 3254663 | 1 | 1 | |
| 2024-03-25 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-038585 | 9509 | ||||||
| 2024-03-25 | SC 13D/A | SC 13D/A | 0001104659-24-038492 | 005-87649 | 24780144 | 34 | 132927 | |||
| 2024-03-21 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-24-072871 | 001-36076 | 24768707 | 34 | 674136 | 1 | 1 |
| 2024-03-20 | 424B5 | 424B5 | 0001193125-24-072868 | 333-275402 | 24768702 | 33 | 566171 | |||
| 2024-03-05 | 4 | 4 | 0000950170-24-025992 | 4607 | ||||||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-001754 | 001-36076 | 24714141 | 33 | 6771 | |||
| 2024-02-26 | 10-K | 10-K | 0000950170-24-020158 | 001-36076 | 24678816 | 34 | 11936677 | 1 | 1 | |
| 2024-02-26 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-020123 | 001-36076 | 24678575 | 34 | 403380 | 1 | 1 |
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020912 | 005-87649 | 24628390 | 34 | 13005 | |||
| 2024-02-12 | SC 13G | ff3013867_13g-fate.htm | 0000895345-24-000042 | 005-87649 | 24621762 | 34 | 198768 | |||
| 2024-02-09 | SC 13G/A | SEC SCHEDULE 13G | 0001422848-24-000230 | 005-87649 | 24616806 | 34 | 18198 | |||
| 2024-02-02 | 4 | 4 | 0000950170-24-010491 | 5376 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010490 | 5356 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010485 | 5382 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010484 | 5379 | ||||||
| 2024-01-30 | 4 | 4 | 0000950170-24-008803 | 4607 | ||||||
| 2024-01-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000484 | 001-36076 | 24572615 | 33 | 6172 | |||
| 2024-01-25 | SC 13G | FATE THERAPEUTICS INC | 0000902664-24-000657 | 005-87649 | 24562418 | 34 | 84938 | |||
| 2024-01-24 | SC 13G/A | us31189p1021_012324.txt | 0001086364-24-002058 | 005-87649 | 24554663 | 34 | 13479 | |||
| 2024-01-22 | SC 13G/A | Fate_Therapeutics_Inc.txt | 0000093751-24-000067 | 005-87649 | 24548053 | 34 | 8428 | |||
| 2024-01-10 | 4 | 4 | 0000950170-24-003652 | 5536 | ||||||
| 2024-01-10 | 4 | 4 | 0000950170-24-003650 | 5559 | ||||||
| 2024-01-10 | 4 | 4 | 0000950170-24-003648 | 5459 | ||||||
| 2024-01-10 | 4 | 4 | 0000950170-24-003647 | 5464 | ||||||
| 2024-01-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000227 | 001-36076 | 24523716 | 33 | 4436 | |||
| 2024-01-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000225 | 001-36076 | 24523704 | 33 | 5476 | |||
| 2024-01-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000224 | 001-36076 | 24523700 | 33 | 4849 | |||
| 2024-01-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000223 | 001-36076 | 24523692 | 33 | 4279 | |||
| 2024-01-03 | 4 | 4 | 0000950170-24-000874 | 4607 | ||||||
| 2024-01-02 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000021 | 001-36076 | 24501263 | 33 | 5528 | |||
| 2023-12-28 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-130203 | 11431 | ||||||
| 2023-12-28 | SC 13D/A | SC 13D/A | 0001104659-23-130098 | 005-87649 | 231523276 | 34 | 75308 | |||
| 2023-12-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-059103 | 4837 | ||||||
| 2023-12-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-005567 | 001-36076 | 231492677 | 33 | 4386 | |||
| 2023-11-27 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-11-27 16:30:00 | 9999999995-23-003442 | 333-275402 | 231441760 | 33 | 1666 | ||
| 2023-11-21 | CORRESP | filename1.htm | 0001193125-23-281480 | 9944 | ||||||
| 2023-11-15 | UPLOAD | filename1.pdf | 0000000000-23-012533 | 40284 | ||||||
| 2023-11-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-054968 | 4730 | ||||||
| 2023-11-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-004622 | 001-36076 | 231391264 | 33 | 5898 | |||
| 2023-11-08 | 8-K | 8-K | 1.01,1.02,9.01 | 0001193125-23-273633 | 001-36076 | 231389194 | 34 | 151465 | 1 | 1 |
| 2023-11-08 | S-3 | S-3 | 0001193125-23-273593 | 333-275402 | 231388865 | 33 | 786664 | |||
| 2023-11-08 | 10-Q | 10-Q | 0000950170-23-061080 | 001-36076 | 231387759 | 34 | 12768949 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-061077 | 001-36076 | 231387709 | 34 | 458021 | 1 | 1 |
| 2023-10-10 | SC 13G/A | Fate_Therapeutics_Inc.txt | 0000093751-23-000682 | 005-87649 | 231316619 | 34 | 8374 | |||
| 2023-09-01 | 8-K | 8-K | 8.01 | 0001193125-23-227749 | 001-36076 | 231233495 | 34 | 144816 | 1 | 1 |
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-046691 | 5501 | ||||||
| 2023-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003379 | 001-36076 | 231185767 | 33 | 4802 | |||
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039803 | 001-36076 | 231151358 | 34 | 13705947 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-039783 | 001-36076 | 231151258 | 34 | 496335 | 1 | 1 |
| 2023-08-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-044768 | 4682 | ||||||
| 2023-08-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002912 | 001-36076 | 231142603 | 33 | 4868 | |||
| 2023-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-041611 | 5482 | ||||||
| 2023-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-041607 | 4755 | ||||||
| 2023-07-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002242 | 001-36076 | 231068245 | 33 | 4174 | |||
| 2023-07-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002236 | 001-36076 | 231067509 | 33 | 4844 | |||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037302 | 4683 | ||||||
| 2023-06-14 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001856 | 001-36076 | 231013372 | 33 | 4287 | |||
| 2023-06-09 | 8-K | 8-K | 5.07 | 0000950170-23-027262 | 001-36076 | 231005315 | 34 | 215665 | 1 | 1 |
| 2023-06-08 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-069540 | 8985 | ||||||
| 2023-06-08 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-069538 | 7246 | ||||||
| 2023-06-08 | 8-K | 8-K | 5.02 | 0000950170-23-027007 | 001-36076 | 231002037 | 34 | 160687 | 1 | 1 |
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035066 | 5788 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035062 | 5749 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035059 | 5636 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035055 | 5784 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035051 | 5737 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035049 | 5643 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035044 | 5840 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035039 | 5760 | ||||||
| 2023-06-07 | 8-K | 8-K | 8.01 | 0000950170-23-026747 | 001-36076 | 23997764 | 34 | 171024 | 1 | 1 |
| 2023-05-10 | SC 13G/A | FATE_THERAPEUTICS_INC.txt | 0000093751-23-000560 | 005-87649 | 23904593 | 34 | 10283 | |||
| 2023-05-03 | 10-Q | 10-Q | 0000950170-23-017175 | 001-36076 | 23883790 | 34 | 11840725 | 1 | 1 | |
| 2023-05-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-017157 | 001-36076 | 23883682 | 34 | 444727 | 1 | 1 |
| 2023-04-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-048557 | 10114 | ||||||
| 2023-04-21 | ARS | ARS | 0001193125-23-110500 | 001-36076 | 23836434 | 34 | 2750513 | |||
| 2023-04-21 | DEFA14A | DEFA14A | 0001193125-23-110484 | 001-36076 | 23836368 | 34 | 36850 | |||
| 2023-04-21 | DEF 14A | DEF 14A | 0001193125-23-110475 | 001-36076 | 23836304 | 34 | 2706138 | 1 | 1 | |
| 2023-04-19 | SC 13D/A | SC 13D/A | 0001104659-23-047252 | 005-87649 | 23830770 | 34 | 93562 | |||
| 2023-04-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-024820 | 7215 | ||||||
| 2023-04-19 | 8-K | 8-K | 3.01,5.03,9.01 | 0000950170-23-013471 | 001-36076 | 23830097 | 34 | 192367 | 1 | 1 |
| 2023-04-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-000617 | 001-36076 | 23826690 | 33 | 4174 | |||
| 2023-04-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-046353 | 36101 | ||||||
| 2023-04-14 | 144 | xsl144X01/primary_doc.xml | 0001104659-23-045209 | 001-36076 | 23819621 | 33 | 11779 | |||
| 2023-03-22 | SC 13G | FATE_SC13G.htm | 0001273087-23-000102 | 005-87649 | 23753103 | 34 | 81948 | |||
| 2023-03-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-030867 | 005-87649 | 23721643 | 34 | 12925 | |||
| 2023-02-28 | 10-K | 10-K | 0000950170-23-005067 | 001-36076 | 23685158 | 34 | 16381768 | 1 | 1 | |
| 2023-02-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-005063 | 001-36076 | 23685064 | 34 | 526195 | 1 | 1 |
| 2023-02-13 | SC 13G | SEC SCHEDULE 13G | 0001422849-23-000056 | 005-87649 | 23617326 | 34 | 18163 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015938 | 005-87649 | 23603192 | 34 | 12926 | |||
| 2023-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-007513 | 5494 | ||||||
| 2023-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-007511 | 5496 | ||||||
| 2023-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-007509 | 5473 | ||||||
| 2023-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-007507 | 5486 | ||||||
| 2023-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-007503 | 5499 | ||||||
| 2023-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-007497 | 5483 | ||||||
| 2023-02-03 | SC 13G | Fate_Therapeutics_Inc.txt | 0000093751-23-000111 | 005-87649 | 23584053 | 34 | 8412 | |||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-004237 | 6605 | ||||||
| 2023-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-003338 | 5823 | ||||||
| 2023-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-003261 | 6800 | ||||||
| 2023-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-002979 | 5673 | ||||||
| 2023-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-002978 | 5673 | ||||||
| 2023-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-002977 | 5650 | ||||||
| 2023-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-002976 | 5486 | ||||||
| 2023-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-002975 | 5578 | ||||||
| 2023-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-002974 | 5659 | ||||||
| 2023-01-06 | SC 13G/A | us31189p1021_010523.txt | 0001306550-23-000063 | 005-87649 | 23514318 | 34 | 13365 | |||
| 2023-01-05 | 8-K | 8-K | 1.02,2.05,5.02,8.01,9.01 | 0001193125-23-002504 | 001-36076 | 23512341 | 34 | 201704 | 1 | 1 |
| 2022-11-07 | 8-K | 8-K | 1.01,7.01,9.01 | 0000950170-22-022488 | 001-36076 | 221364675 | 34 | 262355 | 1 | 1 |
| 2022-11-03 | 10-Q | 10-Q | 0000950170-22-021840 | 001-36076 | 221357893 | 34 | 14664023 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-021834 | 001-36076 | 221357844 | 34 | 570005 | 1 | 1 |
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-046929 | 7040 | ||||||
| 2022-08-03 | 10-Q | 10-Q | 0000950170-22-014236 | 001-36076 | 221132613 | 34 | 13137485 | 1 | 1 | |
| 2022-08-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-014223 | 001-36076 | 221132481 | 34 | 547798 | 1 | 1 |
| 2022-07-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-043143 | 19783 | ||||||
| 2022-07-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-041670 | 9018 | ||||||
| 2022-07-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-041440 | 12783 | ||||||
| 2022-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-041053 | 5484 | ||||||
| 2022-06-30 | 8-K | 8-K | 1.01,7.01,9.01 | 0000950170-22-012381 | 001-36076 | 221058093 | 34 | 225166 | 1 | 1 |
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-039819 | 7413 | ||||||
| 2022-06-29 | 3 | FORM 3 SUBMISSION | 0001209191-22-039817 | 6904 | ||||||
| 2022-06-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-070681 | 11148 | ||||||
| 2022-06-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-070679 | 9194 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036355 | 7289 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036353 | 9165 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036350 | 7138 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036349 | 7284 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036347 | 7238 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036345 | 7144 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036343 | 8628 | ||||||
| 2022-06-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-036338 | 7261 | ||||||
| 2022-06-13 | 8-K | 8-K | 5.02,5.07,9.01 | 0000950170-22-011554 | 001-36076 | 221011699 | 34 | 212108 | 1 | 1 |
| 2022-06-09 | S-8 | S-8 | 0001193125-22-171100 | 333-265502 | 221006445 | 33 | 376294 | |||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-034996 | 5345 | ||||||
| 2022-06-08 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-034992 | 4793 | ||||||
| 2022-06-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-034554 | 5223 | ||||||
| 2022-06-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-034551 | 5369 | ||||||
| 2022-06-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-034546 | 5321 | ||||||
| 2022-06-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-034541 | 5426 | ||||||
| 2022-06-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-034536 | 5344 | ||||||
| 2022-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-033481 | 8585 | ||||||
| 2022-05-04 | 10-Q | 10-Q | 0000950170-22-007389 | 001-36076 | 22891711 | 34 | 11383239 | 1 | 1 | |
| 2022-05-04 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-007377 | 001-36076 | 22891506 | 34 | 469600 | 1 | 1 |
| 2022-04-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-025515 | 21485 | ||||||
| 2022-04-25 | DEFA14A | DEFA14A | 0001193125-22-117538 | 001-36076 | 22849758 | 34 | 60185 | |||
| 2022-04-25 | DEF 14A | DEF 14A | 0001193125-22-117516 | 001-36076 | 22849680 | 34 | 1371173 | |||
| 2022-04-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-025159 | 5458 | ||||||
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-022495 | 12375 | ||||||
| 2022-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-018820 | 15801 | ||||||
| 2022-03-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-018188 | 10540 | ||||||
| 2022-02-28 | S-8 | S-8 | 0001193125-22-058233 | 333-263102 | 22691345 | 33 | 89563 | |||
| 2022-02-28 | 10-K | 10-K | 0000950170-22-002293 | 001-36076 | 22689661 | 34 | 15700082 | 1 | 1 | |
| 2022-02-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-002285 | 001-36076 | 22689336 | 34 | 523790 | 1 | 1 |
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-017527 | 005-87649 | 22609722 | 34 | 12921 | |||
| 2022-02-09 | SC 13G/A | SC 13G/A | 0001104659-22-016155 | 005-87649 | 22605911 | 34 | 40423 | |||
| 2022-02-04 | 4/A | FORM 4/A SUBMISSION | 0000899243-22-004871 | 10096 | ||||||
| 2022-02-03 | SC 13G/A | us31189p1021_020222.txt | 0000834237-22-005412 | 005-87649 | 22585630 | 34 | 13364 | |||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003449 | 7403 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003448 | 7360 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003447 | 7368 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003443 | 7376 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003426 | 5457 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003424 | 7364 | ||||||
| 2022-01-27 | 4/A | FORM 4/A SUBMISSION | 0000899243-22-003421 | 5903 | ||||||
| 2022-01-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-004606 | 13941 | ||||||
| 2022-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-003174 | 7327 | ||||||
| 2022-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-003172 | 7323 | ||||||
| 2022-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-003170 | 7325 | ||||||
| 2022-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-003168 | 7232 | ||||||
| 2022-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-003166 | 7324 | ||||||
| 2022-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-003054 | 8789 | ||||||
| 2022-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-003051 | 7230 | ||||||
| 2022-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-003047 | 7232 | ||||||
| 2022-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-000647 | 14247 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070768 | 8815 | ||||||
| 2021-12-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-356947 | 001-36076 | 211492083 | 34 | 348861 | 1 | 1 |
| 2021-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-069415 | 15974 | ||||||
| 2021-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-21-069313 | 19510 | ||||||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066168 | 10619 | ||||||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066165 | 5016 | ||||||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066163 | 5014 | ||||||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066162 | 5013 | ||||||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066159 | 5019 | ||||||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066156 | 5012 | ||||||
| 2021-11-04 | 8-K | 8-K | 1.01,1.02,9.01 | 0001193125-21-320325 | 001-36076 | 211380927 | 34 | 408433 | 1 | 1 |
| 2021-11-04 | S-3ASR | S-3ASR | 0001193125-21-320314 | 333-260772 | 211380887 | 33 | 992833 | |||
| 2021-11-04 | 10-Q | 10-Q | 0000950170-21-003066 | 001-36076 | 211380095 | 34 | 12510064 | 1 | 1 | |
| 2021-11-04 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-003055 | 001-36076 | 211379948 | 34 | 543896 | 1 | 1 |
| 2021-10-25 | 4 | FORM 4 SUBMISSION | 0001209191-21-061485 | 24091 | ||||||
| 2021-10-12 | SC 13G/A | filing.txt | 0000315066-21-001805 | 005-87649 | 211317256 | 34 | 8449 | |||
| 2021-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-058930 | 12509 | ||||||
| 2021-09-30 | 4 | FORM 4 SUBMISSION | 0001209191-21-058176 | 8810 | ||||||
| 2021-09-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-055867 | 12503 | ||||||
| 2021-09-10 | SC 13G | SC 13G | 0001104659-21-114595 | 005-87649 | 211246822 | 34 | 43306 | |||
| 2021-08-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-052744 | 8606 | ||||||
| 2021-08-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-052742 | 9233 | ||||||
| 2021-08-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-049914 | 7309 | ||||||
| 2021-08-05 | 3 | FORM 3 SUBMISSION | 0001209191-21-049911 | 6863 | ||||||
| 2021-08-04 | 10-Q | 10-Q | 0001564590-21-040821 | 001-36076 | 211144173 | 34 | 11295813 | 1 | 1 | |
| 2021-08-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-040793 | 001-36076 | 211143987 | 34 | 517418 | 1 | 1 |
| 2021-08-04 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-21-235830 | 001-36076 | 211142557 | 34 | 178629 | 1 | 1 |
| 2021-07-26 | 4 | FORM 4 SUBMISSION | 0000899243-21-029868 | 22045 | ||||||
| 2021-07-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-045182 | 37506 | ||||||
| 2021-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-042373 | 11291 | ||||||
| 2021-06-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-042370 | 6955 | ||||||
| 2021-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-040914 | 16360 | ||||||
| 2021-06-07 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-21-184402 | 001-36076 | 211000090 | 34 | 173630 | 1 | 1 |
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-022091 | 7320 | ||||||
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-022090 | 7423 | ||||||
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-022086 | 9248 | ||||||
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-022085 | 7225 | ||||||
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-022081 | 7367 | ||||||
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-022080 | 7343 | ||||||
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-022076 | 7221 | ||||||
| 2021-06-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-077005 | 11235 | ||||||
| 2021-06-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-077002 | 9288 | ||||||
| 2021-05-24 | 4 | FORM 4 SUBMISSION | 0001209191-21-035301 | 8749 | ||||||
| 2021-05-05 | 10-Q | 10-Q | 0001564590-21-024037 | 001-36076 | 21893247 | 34 | 9632027 | 1 | 1 | |
| 2021-05-05 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-024017 | 001-36076 | 21893086 | 34 | 445803 | 1 | 1 |
| 2021-04-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-028259 | 21635 | ||||||
| 2021-04-21 | DEFA14A | DEFA14A | 0001193125-21-124711 | 001-36076 | 21841688 | 34 | 868584 | |||
| 2021-04-21 | DEF 14A | DEF 14A | 0001193125-21-124699 | 001-36076 | 21841665 | 34 | 921391 | |||
| 2021-04-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-027545 | 9850 | ||||||
| 2021-04-07 | PRE 14A | PRE 14A | 0001193125-21-108952 | 001-36076 | 21812685 | 34 | 921384 | |||
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-014635 | 25561 | ||||||
| 2021-04-02 | 3 | FORM 3 SUBMISSION | 0000899243-21-014594 | 11571 | ||||||
| 2021-04-02 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-014588 | 7596 | ||||||
| 2021-03-25 | 8-K | 8-K | 5.02,9.01 | 0001564590-21-015473 | 001-36076 | 21772276 | 34 | 208670 | 1 | 1 |
| 2021-03-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-011920 | 16112 | ||||||
| 2021-03-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-018932 | 18361 | ||||||
| 2021-02-24 | S-8 | S-8 | 0001564590-21-008148 | 333-253459 | 21674186 | 33 | 218761 | |||
| 2021-02-24 | 10-K | 10-K | 0001564590-21-008086 | 001-36076 | 21673181 | 34 | 16569070 | 1 | 1 | |
| 2021-02-24 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-008069 | 001-36076 | 21672955 | 34 | 516645 | 1 | 1 |
| 2021-02-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-012326 | 16874 | ||||||
| 2021-02-10 | SC 13G | SCHEDULE 13G | 0001104659-21-018063 | 005-87649 | 21610692 | 34 | 13844 | |||
| 2021-02-08 | SC 13G/A | filing.txt | 0000315066-21-000992 | 005-87649 | 21599526 | 34 | 8392 | |||
| 2021-02-03 | SC 13G/A | fatetherapeutics13ga1_123120.htm | 0001040188-21-000052 | 005-87649 | 21585248 | 34 | 40638 | |||
| 2021-02-03 | SC 13G/A | fatetherapeutics13ga1_123120.htm | 0001040188-21-000055 | 005-87649 | 21584837 | 34 | 40638 | |||
| 2021-01-29 | SC 13G/A | us31189p1021_012921.txt | 0000834237-21-003910 | 005-87649 | 21568821 | 34 | 13456 | |||
| 2021-01-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-004957 | 42189 | ||||||
| 2021-01-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-004956 | 7371 | ||||||
| 2021-01-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-004955 | 7340 | ||||||
| 2021-01-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-004954 | 7373 |
One latest value per concept from companyfacts (312 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 121.57M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 113.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 574,491 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177094 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 913,398 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177094 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 9.71 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177094 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 26,100 | 2026-11-05 | S-3 | 2026-11-05 | 0001193125-26-450034 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 26,100 | 2026-11-05 | S-3 | 2026-11-05 | 0001193125-26-450034 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 300.00M | 2026-11-05 | S-3 | 2026-11-05 | 0001193125-26-450034 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-05 | S-3 | 2026-11-05 | 0001193125-26-450034 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-05 | S-3 | 2026-11-05 | 0001193125-26-450034 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 3.73M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-13 | 0001104659-13-084191 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesNoncurrent | Accounts Payable and Accrued Liabilities, Noncurrent | USD | 549,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 479,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 2.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 15.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 7.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 36.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -155,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.76B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 248.96M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001564590-17-004614 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.70M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 0 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-13 | 0000950170-25-070285 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 217,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 10.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 24,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 115,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002293 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 36.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | Assets | Assets | USD | 238.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 144.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 2,000 | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040360 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 53.18M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040360 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 55.72M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 51,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040360 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 13,000 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 55.73M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 53.23M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040360 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 37,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | CapitalizedContractCostAmortization | Capitalized Contract Cost, Amortization | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0000950170-25-033510 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 43.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -48.00M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001564590-17-011043 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 139.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 36.39M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-06 | 0001564590-18-019456 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 49.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -7.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 100 | 2023-11-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 230,000 | 2013-10-04 | 2013 | FY | 10-K | 2014-03-17 | 0001047469-14-002516 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 50.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 350.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 121.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 121.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 122,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -92.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | ContractsRevenue | Contracts Revenue (Deprecated 2018-01-31) | USD | 1.03M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 59.70M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 22.47M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | ContractualObligationDueInFifthYear | Contractual Obligation, to be Paid, Year Five | USD | 4.11M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | ContractualObligationDueInFourthYear | Contractual Obligation, to be Paid, Year Four | USD | 5.62M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 6.74M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 10.58M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | ContractualObligationDueInThirdYear | Contractual Obligation, to be Paid, Year Three | USD | 10.19M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | ContractWithCustomerAssetNetNoncurrent | Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-020158 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005067 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 56.53M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 20.00M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-13 | 0001104659-13-084191 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 23.70M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-13 | 0001104659-13-084191 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 3.48M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-13 | 0001104659-13-084191 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 7.23M | 2013-09-13 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 | |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 22.08M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | 22.10M | 2013-10-04 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 15.00M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 | |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 336,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 15.00M | 2017-07-14 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001564590-20-024213 | |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | -371,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 268.11M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061080 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 499,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061080 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 11.36M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 12,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 3.40M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 5.46M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001104659-15-075283 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 2.10M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 198,000 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 2.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 8.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 399.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxAssetsNetNoncurrent | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 186.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 36,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 1.65M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 66.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 6.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 387.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 387.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | -1.11M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 600,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005067 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 8.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 93.49M | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-13 | 0001104659-14-038138 | |
| us-gaap | Dividends | Dividends | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005067 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.76 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.68 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007389 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.76 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.186 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.043 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.076 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.022 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 1.23M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 31.00M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0000950170-24-096187 | |
| us-gaap | EquityIssuancePerShareAmount | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | USD | 6 | 2013-10-04 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 | |
| us-gaap | ExtinguishmentOfDebtGainLossNetOfTax | Extinguishment of Debt, Gain (Loss), Net of Tax | USD | 3,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001104659-14-079407 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 8,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007389 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007389 | |
| us-gaap | FairValueInstrumentsClassifiedInShareholdersEquityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss | Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Change in Unrealized Gain (Loss) (Deprecated 2019-01-31) | USD | -2.42M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002293 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002293 | |
| us-gaap | FinancingReceivableNonaccrualNoAllowance | Financing Receivable, Nonaccrual, No Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -18,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -118,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 26.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1,600 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 1,600 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 25.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -28.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 5.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 108,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 202,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -10.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.95M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -4.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -437,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -381,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 515,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 122,000 | 2007-04-27 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-13 | 0001104659-14-038138 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 3.00M | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-07 | 0001564590-16-027939 |
| us-gaap | InterestExpense | Interest Expense | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002293 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 1.80M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002293 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 2.31M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-05 | 0001564590-18-004394 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 2.29M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002293 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 4.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 335,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 |
| us-gaap | InvestmentTaxCredit | Investment Tax Credit | USD | -1.23M | 2007-04-27 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-13 | 0001104659-14-038138 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 13,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 2.30M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008086 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.08 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-06 | 0001564590-19-029333 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 111.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 53.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 11.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 11.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 10.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 10.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 10.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 2.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 36.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LettersOfCreditOutstandingAmount | Letters of Credit Outstanding, Amount | USD | 10.10M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-13 | 0001193125-26-220696 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 238.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 32.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 18.48M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 2.44M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 3.72M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 1.54M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-05 | 0001564590-18-004394 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 1.63M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 6.31M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 6.82M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 12.45M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 9.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 355,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 64.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -43.84M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -82.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -30.80M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-13 | 0001193125-26-220696 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -92.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | NetRentableArea | Net Rentable Area | sqft | 72,000 | 2024-10-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347988 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Disbursement | 1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-020158 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 99.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -96.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 15.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 3.50M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001564590-20-024213 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 74.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 5.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 69.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 40.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 41.22M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 3.02M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 4.11M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 3.99M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 3.87M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 3.76M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 22.47M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006258 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.085 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 4.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -271,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -38,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent | Other Employee-related Liabilities | USD | 12.90M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061080 | |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 2.00M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-020158 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 4.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 10.90M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-020158 |
| us-gaap | OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld | Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-020158 | |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale | USD | 0 | 2020-01-01 | 2020-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities | Other than Temporary Impairment Losses, Investments, Available-for-sale Securities | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012939 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 373,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008086 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 7,000 | 2007-04-27 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-13 | 0001104659-14-038138 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 88,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 10,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 5.50M | 2024-01-01 | 2024-03-31 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125317 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 104.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 319,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 106.18M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040360 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 2.76M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0000950170-24-096187 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 2.76M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0000950170-24-096187 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 4.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 23.74M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 7.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 58.65M | 2007-04-27 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-13 | 0001104659-13-084191 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 15.00M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 16.73M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 20.00M | 2024-01-01 | 2024-03-31 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001193125-25-279096 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 64.05M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040360 |
| us-gaap | ProceedsFromRepaymentsOfDebt | Proceeds from (Repayments of) Debt | USD | 7.50M | 2017-07-13 | 2017-07-14 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 |
| us-gaap | ProceedsFromRepurchaseOfEquity | Proceeds from (Repurchase of) Equity | USD | 287,000 | 2007-04-27 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-13 | 0001104659-13-084191 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 170.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 435,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -92.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 93.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 48.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | RecognitionOfDeferredRevenue | Recognition of Deferred Revenue | USD | -7.91M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001104659-15-075283 |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 1.68M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 15.00M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002293 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 73.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 10.05M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347988 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 5.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.6 | 2023-01-01 | 2023-01-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-020158 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 1.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.63B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 3.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 345,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125317 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 74.50M | 2024-01-01 | 2024-03-31 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125317 |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 1.03M | 2017-10-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-05 | 0001564590-18-004394 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 2.40M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 2.00M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-020158 |
| us-gaap | SharePrice | Share Price | USD/shares | 2.12 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061080 | |
| us-gaap | SharesIssued | Shares, Issued | shares | 2.76M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061080 | |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 96.86M | 2022-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039803 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 95.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-09 | 0000950170-24-056869 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 133.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.154 | 2013-09-12 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 | |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 3.68M | 2013-10-03 | 2013-10-04 | 2013 | FY | 10-K | 2014-03-17 | 0001047469-14-002516 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005067 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 37,641 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001564590-17-004614 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 7.67M | 2013-10-03 | 2013-10-04 | 2015 | Q1 | 10-Q | 2015-05-07 | 0001104659-15-035555 |
| us-gaap | StockIssuedDuringPeriodSharesPurchaseOfAssets | Stock Issued During Period, Shares, Purchase of Assets | shares | 480,763 | 2013-10-03 | 2013-10-04 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardGross | Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares | 0 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-020158 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 56.53M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForCash | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | USD | 192,000 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001047469-15-002070 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 6.10M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008086 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 432.28M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005067 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 23,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | 7,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-17 | 0001047469-14-002516 |
| us-gaap | StraightLineRent | Straight Line Rent | USD | -192,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008086 |
| us-gaap | StraightLineRentAdjustments | Straight Line Rent Adjustments | USD | 11.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 273,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-09 | 0000950170-24-056869 |
| us-gaap | TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit | Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) | USD | 25.28M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-008141 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 56.53M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-17 | 0001047469-14-002516 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 58.52M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-13 | 0001104659-13-084191 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.001 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-17 | 0001047469-14-002516 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 68.36M | 2013-09-13 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-17 | 0001047469-14-002516 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 44.97M | 2013-09-13 | 2015 | FY | 10-K | 2016-03-03 | 0001564590-16-013981 | |
| us-gaap | TenantImprovements | Tenant Improvements | USD | 2.50M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 82.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 11.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 275,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0000950170-25-033510 | |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 3.19M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073699 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 184,000 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-17 | 0001047469-14-002516 | |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 117.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 121.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 96.34M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007389 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 121.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448543 |
| us-gaap | WriteOffOfDeferredDebtIssuanceCost | Write off of Deferred Debt Issuance Cost | USD | 30,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-05 | 0001564590-18-004394 |